Advances in 4-Hydroxycoumarin Chemistry: Functionalization, Prominent 4-Hydroxycoumarin-based Therapeutics and Their...

This review discusses recent advances in 4-hydroxycoumarin (4-HC) and its derivatives, emphasising its promise as a versatile pharmacological agent with diverse bioactivities.

4-Hydroxycoumarin (4-HC) represents a pivotal heterocyclic compound widely recognized in medicinal and pharmaceutical chemistry, serving as a central scaffold for the development of various therapeutic agents. The derivatives of 4-HC have garnered considerable attention due to their broad range of pharmacological activities, including antibacterial, antiviral, antifungal, anti-inflammatory, and anticancer effects.

This review employs a combined bibliosemantic and analytical approach, utilizing major bibliographic databases and specialized chemical repositories to extract, categorize, and evaluate relevant studies on 4-HC derivatives. Emphasis is placed on literature from 2018 onwards.

The review presents a systematic overview of structurally diverse 4-HC derivatives, elucidating the synthetic strategies employed for their functionalization. Their pharmacological profiles are critically examined across distinct therapeutic domains. Structurally and mechanistically relevant analogues, such as clinically established anticoagulants, are highlighted. The derivatives are discussed according to their primary bioactivities to ensure clarity and prevent redundancy.

The study highlights 4-HC as an important scaffold in medicinal chemistry. Structural adaptability and functionalization enable the synthesis of derivatives with targeted pharmacological effects. While significant advancement has been made, further investigation into structure-activity relationships and mechanistic insights will improve the rational design of next-generation therapeutics.

4-Hydroxycoumarin and its derivatives exhibit substantial promise as lead scaffolds in drug discovery. Their structural adaptability and diverse biological targets position them as valuable candidates for generating novel therapeutic agents across multiple disease spectra.